Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Marjatta Leirisalo-Repo, Hannu Kautiainen, Leena Laasonen, Markku Korpela, Markku J. Kauppi, Oili Kaipiainen-Seppanen, Riitta Anneli Luosujärvi, Reijo Luukkainen, Anna Karjalainen, Harri Blafield, Toini Uutela, Kirsti Ilva, Heikki A. Julkunen, Leena Paimela, Kari Puolakka, Eeva Moilanen, Pekka J. Hannonen, Timo Mottonen, NEO-RACo Study Grp

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume72
Issue number6
Pages (from-to)851-857
Number of pages7
ISSN0003-4967
DOIs
Publication statusPublished - Jun 2013
MoE publication typeA1 Journal article-refereed

Fields of Science

  • MODIFYING ANTIRHEUMATIC DRUGS
  • CONTROLLED-TRIAL
  • METHOTREXATE MONOTHERAPY
  • DISEASE-ACTIVITY
  • CLINICAL-TRIALS
  • TIGHT CONTROL
  • FOLLOW-UP
  • REMISSION
  • SULFASALAZINE
  • ETANERCEPT
  • 3121 Internal medicine

Cite this

Leirisalo-Repo, Marjatta ; Kautiainen, Hannu ; Laasonen, Leena ; Korpela, Markku ; Kauppi, Markku J. ; Kaipiainen-Seppanen, Oili ; Luosujärvi, Riitta Anneli ; Luukkainen, Reijo ; Karjalainen, Anna ; Blafield, Harri ; Uutela, Toini ; Ilva, Kirsti ; Julkunen, Heikki A. ; Paimela, Leena ; Puolakka, Kari ; Moilanen, Eeva ; Hannonen, Pekka J. ; Mottonen, Timo ; NEO-RACo Study Grp. / Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). In: Annals of the Rheumatic Diseases. 2013 ; Vol. 72, No. 6. pp. 851-857.
@article{84e910170d5b48f08441a117a7b3e2b5,
title = "Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)",
keywords = "MODIFYING ANTIRHEUMATIC DRUGS, CONTROLLED-TRIAL, METHOTREXATE MONOTHERAPY, DISEASE-ACTIVITY, CLINICAL-TRIALS, TIGHT CONTROL, FOLLOW-UP, REMISSION, SULFASALAZINE, ETANERCEPT, 3121 Internal medicine",
author = "Marjatta Leirisalo-Repo and Hannu Kautiainen and Leena Laasonen and Markku Korpela and Kauppi, {Markku J.} and Oili Kaipiainen-Seppanen and Luosuj{\"a}rvi, {Riitta Anneli} and Reijo Luukkainen and Anna Karjalainen and Harri Blafield and Toini Uutela and Kirsti Ilva and Julkunen, {Heikki A.} and Leena Paimela and Kari Puolakka and Eeva Moilanen and Hannonen, {Pekka J.} and Timo Mottonen and {NEO-RACo Study Grp}",
year = "2013",
month = "6",
doi = "10.1136/annrheumdis-2012-201365",
language = "English",
volume = "72",
pages = "851--857",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group Ltd",
number = "6",

}

Leirisalo-Repo, M, Kautiainen, H, Laasonen, L, Korpela, M, Kauppi, MJ, Kaipiainen-Seppanen, O, Luosujärvi, RA, Luukkainen, R, Karjalainen, A, Blafield, H, Uutela, T, Ilva, K, Julkunen, HA, Paimela, L, Puolakka, K, Moilanen, E, Hannonen, PJ, Mottonen, T & NEO-RACo Study Grp 2013, 'Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)', Annals of the Rheumatic Diseases, vol. 72, no. 6, pp. 851-857. https://doi.org/10.1136/annrheumdis-2012-201365

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). / Leirisalo-Repo, Marjatta; Kautiainen, Hannu; Laasonen, Leena; Korpela, Markku; Kauppi, Markku J.; Kaipiainen-Seppanen, Oili; Luosujärvi, Riitta Anneli; Luukkainen, Reijo; Karjalainen, Anna; Blafield, Harri; Uutela, Toini; Ilva, Kirsti; Julkunen, Heikki A.; Paimela, Leena; Puolakka, Kari; Moilanen, Eeva; Hannonen, Pekka J.; Mottonen, Timo; NEO-RACo Study Grp.

In: Annals of the Rheumatic Diseases, Vol. 72, No. 6, 06.2013, p. 851-857.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

AU - Leirisalo-Repo, Marjatta

AU - Kautiainen, Hannu

AU - Laasonen, Leena

AU - Korpela, Markku

AU - Kauppi, Markku J.

AU - Kaipiainen-Seppanen, Oili

AU - Luosujärvi, Riitta Anneli

AU - Luukkainen, Reijo

AU - Karjalainen, Anna

AU - Blafield, Harri

AU - Uutela, Toini

AU - Ilva, Kirsti

AU - Julkunen, Heikki A.

AU - Paimela, Leena

AU - Puolakka, Kari

AU - Moilanen, Eeva

AU - Hannonen, Pekka J.

AU - Mottonen, Timo

AU - NEO-RACo Study Grp

PY - 2013/6

Y1 - 2013/6

KW - MODIFYING ANTIRHEUMATIC DRUGS

KW - CONTROLLED-TRIAL

KW - METHOTREXATE MONOTHERAPY

KW - DISEASE-ACTIVITY

KW - CLINICAL-TRIALS

KW - TIGHT CONTROL

KW - FOLLOW-UP

KW - REMISSION

KW - SULFASALAZINE

KW - ETANERCEPT

KW - 3121 Internal medicine

U2 - 10.1136/annrheumdis-2012-201365

DO - 10.1136/annrheumdis-2012-201365

M3 - Article

VL - 72

SP - 851

EP - 857

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -